Talzenna 1 mg/1 (Talazoparib CAPSULE, LIQUID FILLED) 1 mg/1

Talzenna 1 mg/1 is a liquid-filled capsule containing talazoparib, used for targeted therapy. This medication is designed for oral administration and is manufactured by Pfizer Laboratories.

Strength

1 mg/1

Pack Size

30 CAPSULE, LIQUID FILLED in 1 BOTTLE (0069-0757-30)

Manufacturer / TM Owner

Pfizer Laboratories Div Pfizer Inc

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Talzenna 1 mg/1 is primarily used in the treatment of certain types of cancer. Talazoparib is a PARP inhibitor, which works by targeting specific enzymes involved in DNA repair. This medication is often prescribed for patients with specific genetic mutations that affect DNA repair mechanisms. What is Talzenna used for? It is typically used in the management of advanced or metastatic cancer types that have shown a response to PARP inhibitors.

Side Effects

Common effects of Talzenna 1 mg/1 may include fatigue, nausea, and anemia. Some patients may also experience vomiting, decreased appetite, and low blood cell counts. These effects can vary in severity and may require monitoring by a healthcare professional.

Precautions & Warnings

Talzenna 1 mg/1 should be handled with care and stored as directed. It is important to follow the prescribed dosage and administration instructions. Patients should be aware of potential side effects and report any severe or persistent symptoms to their healthcare provider. Pregnant women or those planning to become pregnant should consult their doctor before using this medication.

Avoid Interactions

Talzenna 1 mg/1 may interact with certain medications, including those that affect liver enzymes. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and other substances that affect liver function should be used with caution while taking this medication.

Frequently Asked Questions

Talzenna 1 mg/1 is used in the treatment of certain types of cancer, particularly those with specific genetic mutations that affect DNA repair.

Talzenna 1 mg/1 is taken orally, typically as directed by a healthcare professional. The liquid-filled capsules should be swallowed whole with water.

Common side effects may include fatigue, nausea, anemia, vomiting, decreased appetite, and low blood cell counts.

Talzenna 1 mg/1 may interact with certain medications, so it is important to consult a healthcare provider before combining it with other treatments.

Pregnant women or those planning to become pregnant should consult their doctor before using Talzenna 1 mg/1, as it may have potential risks.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.